Cargando…
Intrathecal Trastuzumab Treatment of the Neoplastic Meningitis due to Breast Cancer: A Case Report and Review of the Literature
We report the case of a 65-year-old woman, diagnosed with a breast cancer human epidermal growth factor receptor (HER2) previously negative, who developed leptomeningeal carcinomatosis and was treated with intrathecal (IT) trastuzumab (TST). After five doses of IT trastuzumab, at escalading doses, o...
Autores principales: | Dumitrescu, Cristina, Lossignol, Dominique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568912/ https://www.ncbi.nlm.nih.gov/pubmed/23424693 http://dx.doi.org/10.1155/2013/154674 |
Ejemplares similares
-
Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine
por: Jaeckle, K A, et al.
Publicado: (2001) -
Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitis.
por: Moseley, R. P., et al.
Publicado: (1990) -
Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis
por: Park, Won-Young, et al.
Publicado: (2016) -
Clinical Outcome of Neoplastic Meningitis Associated with Breast Cancer
por: Abraham, Anju Anna, et al.
Publicado: (2022) -
Long-term complete response to intrathecal trastuzumab in a patient with leptomeningeal carcinomatosis due to her2- overexpressing breast cancer: Case report
por: García, Francisco José Valdivia, et al.
Publicado: (2020)